PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2042578
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2042578
Resuscitation Devices Market size was valued at US$ 5,379.93 Million in 2025, expanding at a CAGR of 8.10% from 2026 to 2033.
Resuscitation devices are medical tools designed to help restore or support breathing and heart function when a person experiences sudden cardiac arrest or severe breathing failure. These devices are used in emergencies to provide immediate life-saving assistance until advanced medical care becomes available. They are commonly used in hospitals, ambulances, and public emergency settings, supporting rapid intervention during critical health events and improving the chances of patient survival.
From a global perspective, the market is influenced by growing attention to emergency care systems and healthcare preparedness initiatives. The World Health Organisation (WHO) emphasises strengthening emergency and critical care services as part of improving health system response to life-threatening conditions. Regulatory authorities such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) ensure safety and performance standards for resuscitation equipment, supporting reliable use in clinical practice. These institutional efforts encourage wider availability and adoption of life-support devices across the healthcare infrastructure.
Resuscitation Devices Market- Market Dynamics
Increasing priority on enhancing the rapid response infrastructure for better cardiac emergency outcomes
One major driver is the rising focus on improving emergency response systems and survival outcomes in cardiac arrest cases. Government actions are supporting wider deployment of automated external defibrillators (AEDs) and CPR-support tools in public areas. For example, the U.S. Department of Health and Human Services (DHHS) has supported community AED placement programs through federal funding initiatives aimed at enhancing emergency preparedness in public spaces.
Similarly, in the United Kingdom, the Department of Health and Social Care (DHSC) has provided financial assistance for the provision of defibrillators to the community so that response times can be reduced during a cardiac event. About the industry, Stryker (through its LIFEPAK defibrillators) has noted the growing use of intelligent emergency response devices, as evidenced by their increasing use in emergency medical services.
The Global Resuscitation Devices Market is segmented on the basis of Product Type, Patient Type, End User, and Region.
Based on patient type, the resuscitation devices market is largely driven by the adult patient group, as cardiac arrest, respiratory failure, and trauma-related emergencies are more frequently observed in this population across hospital and pre-hospital settings. Healthcare systems continue to prioritise rapid intervention tools such as defibrillators, ventilators, and airway management devices for adult emergency care, supporting broader utilization in ambulances and intensive care units. Example: Philips Healthcare has increased its use of automated external defibrillators that are meant mainly to help adults during emergencies. The innovations demonstrate increasing use of innovative resuscitation equipment for adult critical care.
Under the end-user category, the hospital setting holds a significant share in the resuscitation devices market, as these facilities serve as primary centres for managing critical emergencies such as cardiac arrest, respiratory failure, and trauma care. Hospitals are equipped with advanced infrastructure and trained personnel, enabling immediate use of defibrillators, ventilators, and airway management tools during time-sensitive situations. For instance, GE HealthCare has expanded its critical care solutions, including advanced patient monitoring and ventilation systems widely integrated into hospital emergency and intensive care units. Similarly, Dragerwerk AG & Co. KGaA has augmented its suite of ventilators and airway management devices to enhance hospital-based resuscitation procedures. This is indicative of the continuous integration of sophisticated life-support devices into hospitals to facilitate efficient emergency care procedures.
Resuscitation Devices Market- Geographical Insights
North America accounts for a significant share of global revenue in the resuscitation devices market, owing to its close alignment with emergency healthcare systems and an emphasis on providing rapid cardiac assistance. The HHS in the United States has been supporting various national-level programs that advocate for the installation of automated external defibrillators in public locations. The Centers for Disease Control and Prevention (CDC) operates the CARES registry that collects cardiac arrest data and supports improvement in survival practices across hospitals and emergency services. The Centers for Medicare & Medicaid Services (CMS) also reinforces hospital readiness by supporting reimbursement frameworks for advanced emergency cardiovascular care procedures.
In terms of the industry contribution, Stryker Corporation (Physio-Control) has improved its LIFEPAK defibrillation systems, which are commonly used for treating adult cardiac arrest cases in EMS environments. This innovation is indicative of the increasing use of sophisticated resuscitation devices in adult critical care protocols. Such cooperation between government agencies and industry players will contribute to greater adoption of resuscitation devices.
U.S Resuscitation Devices Market- Country Insights
In the United States, growing emphasis on strengthening emergency medical response systems is supporting wider adoption of resuscitation devices in hospitals and public spaces. The U.S. Department of Health and Human Services (HHS) has supported community emergency preparedness programs that encourage placement of automated external defibrillators in high-traffic locations, helping improve immediate response during cardiac arrest events. Moreover, the Cardiac Arrest Registry to Enhance Survival program of the CDC monitors the results of cardiac arrests and facilitates improvements in CPR quality and emergency management based on data analysis. On the industry side, Philips Healthcare has strengthened its presence in the U.S. emergency care ecosystem by advancing connected defibrillator systems that support real-time guidance and faster clinical decision-making during resuscitation events. These initiatives are aligning with healthcare providers' focus on improving survival chances through timely intervention and better-equipped emergency response networks.
The resuscitation devices market is characterised by active participation from established medical technology firms and emerging healthcare equipment developers, supported by continuous advancements in emergency care solutions and cardiac support systems. Efforts are being made to enhance portability, ease of use, and immediate feedback regarding performance for quick action during cardiac emergencies. The distribution of devices takes place through hospital procurement processes, medical distributors, and digital health procurement systems. Emphasis is also placed on continuous product refinement, training support, and digital integration to strengthen adoption in emergency response systems.
For instance, ZOLL Medical Corporation has recently advanced its cloud-connected defibrillator systems designed to provide real-time CPR guidance and post-event data analysis for better clinical decision-making. Similarly, Laerdal Medical has enhanced its simulation-based resuscitation training platforms, supporting healthcare professionals in improving emergency preparedness and response accuracy. These developments reflect a steady movement toward improving usability, training efficiency, and response reliability across critical care environments, supporting broader acceptance of advanced resuscitation technologies.
In July 2025, Medtronic plc entered into a collaboration with emergency care solution providers to improve airway management device design, focusing on safer intubation support in critical care situations. Collaboration supports improved airway management innovation, enhancing safety, precision, and reliability in critical emergency intubation procedures.
In April 2025, Nihon Kohden Corporation expanded its cardiac monitoring and defibrillation ecosystem by upgrading connectivity features for real-time patient monitoring in ambulances and emergency units. Strengthening connectivity-driven cardiac care systems supports faster emergency response and improved real-time patient monitoring in critical situations.